Topic Hub
8 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 8 of 8 clinical reviews.
A clinician-level guide to managing adverse events from selective estrogen receptor modulators (SERMs), including tamoxifen, raloxifene, clomiphene, and enclomiphene. Covers mechanism, class-specific toxicities, and evidence-based mitigation strategies.
Read clinical reviewA clinician-level guide to selective estrogen receptor modulator (SERM) billing codes, prior-authorization strategies, step-therapy requirements, and appeal tactics for tamoxifen, raloxifene, clomiphene, toremifene, ospemifene, and enclomiphene.
Read clinical reviewA comprehensive MD/PharmD-level monograph on selective estrogen receptor modulators (SERMs): mechanisms, tissue selectivity, approved indications, dosing, drug interactions, and clinical trial evidence.
Read clinical reviewA clinical-grade drug-drug interaction (DDI) table for selective estrogen receptor modulators, covering tamoxifen, raloxifene, clomiphene, enclomiphene, ospemifene, and bazedoxifene. Written at MD/PharmD level with dosing notes, mechanism data, and management strategies.
Read clinical reviewA prescriber-level guide to monitoring selective estrogen receptor modulators (SERMs) including enclomiphene, tamoxifen, raloxifene, and clomiphene. Covers baseline labs, on-therapy surveillance, imaging intervals, and discontinuation protocols.
Read clinical reviewA clinical-level review of selective estrogen receptor modulators (SERMs) in special populations including men, postmenopausal women, adolescents, and patients with renal or hepatic impairment. Covers enclomiphene, tamoxifen, raloxifene, ospemifene, and bazedoxifene with real doses, trials, and guidelines.
Read clinical reviewEvidence-based titration and tapering protocols for selective estrogen receptor modulators (SERMs) including enclomiphene, tamoxifen, raloxifene, and clomiphene. Dose-escalation schedules, monitoring intervals, and discontinuation strategies for clinicians.
Read clinical reviewA prescriber-level guide to choosing among tamoxifen, raloxifene, clomiphene, enclomiphene, toremifene, and ospemifene based on tissue selectivity, clinical indication, and patient-specific risk factors.
Read clinical review